SCHEMBL20151862

SCHEMBL20151862

COC(=O)C1(Oc2cc(C)ccc2C=O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.38
ALDH1A1 P00352 5/20 0.36
SRC P12931 1/20 0.36
POLA1 P09884 2/20 0.35
LPAR1 Q92633 3/20 0.34
MAPT P10636 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
PKM P14618 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HPGD P15428 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TRIM24 O15164 1/20 0.33
TYR P14679 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20570798 0.85 ERN1 (0.39) ERN1ALDH1A1SRCPOLA1HPGD
SCHEMBL20137021 0.82 KDM4E (0.39) ALDH1A1MAPTCYP2C9CYP2C19HSD17B10
SCHEMBL20182572 0.81 ALDH1A1 (0.43) ERN1ALDH1A1SRCCYP2C9CYP2C19
SCHEMBL31645176 0.81 KMT2A (0.37) LPAR1MAPTCYP3A4CYP2C9PKM
SCHEMBL22116340 0.76 LPAR1 (0.37) LPAR1CYP3A4CYP2C9PKMCYP2C19
SCHEMBL13847857 0.74 HPGD (0.42) ALDH1A1LPAR1MAPTHPGDSMN1; SMN2
SCHEMBL22116318 0.74 PTGDR2 (0.46) ALDH1A1LPAR1PKMHPGDSMN1; SMN2
SCHEMBL2428471 0.73 ERN1 (0.40) ERN1ALDH1A1POLA1MAPTPKM
SCHEMBL22116398 0.72 SLC9A3 (0.33) SRCCYP2C9NPSR1LMNAL3MBTL1
SCHEMBL96209 0.71 ALDH1A1 (0.66) ERN1ALDH1A1MAPTCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691975-B2 MAGL inhibitors H. LUNDBECKA/S (DK) 2023-07-04 US disclosed
US-20180134674-A1 MAGL INHIBITORS H. LUNDBECK A/S (DK) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134674-A1 MAGL INHIBITORS MAG, MAGI3, MGLL ERN1 3681/4885ALDH1A1 4349/4885SRC 3069/4885
US-11691975-B2 MAGL inhibitors MAG, MAGI3, MGLL ERN1 2045/4885ALDH1A1 4002/4885SRC 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.